OncoCyte Corporation Gains 12.05%
Thu, Jan 20, 2022 at 05:35 PM
OncoCyte Corporation (OCX:NASDAQ) soared at $1.86, a gain of 12%. On Wed, Jan 19, 2022, OCX:NASDAQ touched a New 2-Week Low of $1.66. The stock got featured on our News Catalysts scanner on Tue, Jan 18, 2022 at 05:01 PM in the 'AGREEMENT' category. From Thu, Jan 06, 2022, the stock recorded 25.00% Up Days and 11.11% Green Days
About OncoCyte Corporation (OCX:NASDAQ)
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer.
Top 10 Gainers:
- Aptorum Group Limited (APM:NASDAQ), 38.52%
- Hillstream BioPharma Inc. (HILS:NASDAQ), 21.79%
- AMTD International Inc. (HKIB:NYSE), 16.63%
- Adagio Therapeutics Inc. (ADGI:NASDAQ), 16.04%
- Amesite Inc. (AMST:NASDAQ), 15.93%
- Pintec Technology Holdings Limited (PT:NASDAQ), 15.19%
- Bragg Gaming Group Inc. (BRAG:NASDAQ), 14.65%
- Society Pass Incorporated (SOPA:NASDAQ), 12.45%
- HCW Biologics Inc. (HCWB:NASDAQ), 12.08%
- OncoCyte Corporation (OCX:NASDAQ), 12.05%